CSF analysis revealed protein of 189 mg/dl, total nucleated cells of 2. Serology was positive for GD1b IgG antibody (52 IV). Lyme disease, sarcoidosis, meningitis, brain stem encephalitis, HIV, syphilis, HTLV, HSV, tuberculosis and vasculitis were negative in laboratory workup. MRI spine showed nerve root enhancement at cervico-thoracic levels. Nerve conduction study in bilateral legs revealed sensory-motor neuropathy.
Patient was initially treated with five days of intravenous immunoglobulin pharmacotherapy and later with physical therapy (PT). After one month facial diplegia resolved, leg weakness and sensory ataxia were evident. Patient continued to get PT and after 6 months only residual leg weakness was present.